UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000008501
Receipt number R000009542
Scientific Title Attain Success Japan Study
Date of disclosure of the study information 2012/07/24
Last modified on 2016/01/27 11:58:47

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Attain Success Japan Study

Acronym

Attain Success Japan Study

Scientific Title

Attain Success Japan Study

Scientific Title:Acronym

Attain Success Japan Study

Region

Japan


Condition

Condition

Heart Failure

Classification by specialty

Cardiology Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Medtronic Japan co., Ltd. is sponsoring the Attain Success Japan Study, a prospective, non-randomized, multi-center, post-market observational clinical trial. The purpose of this trial is to assess Attain left-heart lead implant success and related complication rate.
For the Attain Success Study, implant success is defined as final successful placement of the left-heart lead in the coronary vein branch.
All subjects who have had the Attain left-heart lead implant attempt will be used to consider Attain left-heart lead implant success rate. All Subject who have had a successful Attain left-heart lead implant will be used to consider Attain left-heart lead related complication rate.

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

1. To assess the implant success rate for the Attain left-heart leads.
2. To assess Attain left-heart lead related complication rate through three months.

Key secondary outcomes

1. To assess left-heart pacing threshold measured by left ventricular capture management (LVCM) and manual left ventricular capture threshold test at three month visit.


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. Subject is at least 20 years of age or older.
2. Subject will be implanted with Medtronic CRT device and Medtronic left-heart lead. The implant procedure may include upgrades to CRT from IPG or ICD.
3. Subject satisfies indications for Japanese CRT implantation.

Key exclusion criteria

1. Subject is enrolled in a concurrent study with the exception of a study approved by the Medtronic Clinical Trial Leader prior to enrollment.
2. Subject has existing CRT system implanted or was previously implanted with a CRT system.
3. Subject who will undergo an implant of either Medtronic Model 5071 Sutureless Myocardial Pacing Lead, Model 4968 CapSure Epi bipolar Epicardial Pacing Lead, or Model 4965 Epicardial Pacing Lead used as left-heart lead.

Target sample size

347


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Kenji Ando

Organization

Kokura Memorial Hospital

Division name

Department of Cardiology

Zip code


Address

3-2-1, Asano, Kokura Kita-ku, Kitakyushu, Fukuoka

TEL

093-511-2000

Email

kenji-ando@live.jp


Public contact

Name of contact person

1st name
Middle name
Last name Hiroyuki Yoshimura

Organization

Medtronic Japan Co., Ltd.

Division name

CRHF Clinical

Zip code


Address

2-1-14 Higashi Shimbashi, Minato-ku, Tokyo 105-0021 Japan

TEL

03-6430-7023

Homepage URL


Email

hiroyuki.yoshimura@medtronic.com


Sponsor or person

Institute

Medtronic Japan Co., Ltd.

Institute

Department

Personal name



Funding Source

Organization

Medtronic Japan Co., Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2012 Year 07 Month 24 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2012 Year 05 Month 22 Day

Date of IRB


Anticipated trial start date

2012 Year 06 Month 05 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Prospective, non-randomized, multicenter, observational study.


Management information

Registered date

2012 Year 07 Month 23 Day

Last modified on

2016 Year 01 Month 27 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000009542


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name